KU ASH 2019 Review: Current Updates in Hematologic Diseases

 

KU ASH 2019 Review: Current Updates in Hematologic Diseases
R

ASH 2019 Update on Myeloproliferative Neoplasms: CPI-0610 (BET Inhibitor) Mono or + Ruxolitinib Demonstrated Antitumor Activity in R/R/I Disease

By KU ASH 2019 Review: Current Updates in Hematologic Diseases FEATURING Ronald Hoffman
By KU ASH 2019 Review: Current Updates in Hematologic Diseases FEATURING Ronald Hoffman
0 views
February 13, 2020
Comments 0
Login to view comments. Click here to Login

Featured Video

24:44
Indy Hematology Review

State of the Art in 2024: Emerging Therapies in Hematologic Malignan…

Feat. R. Birhiray

Featured Video

11:12
Stemline

A proven CD123 targeted therapy for BPDCN

Feat. H. Erba
Myeloid Session
13:23
KU ASH 2019 Review: Current Updates in Hematologic Diseases

ASH 2019 Update on MDS: Definitions and the Notion of Risk

Feat. M. Sekeres
14:52
KU ASH 2019 Review: Current Updates in Hematologic Diseases

ASH 2019 Update on Low-Risk MDS: Ameliorating Anemia

Feat. M. Sekeres
05:28
KU ASH 2019 Review: Current Updates in Hematologic Diseases

ASH 2019 Update on Low-Risk MDS: Tackling Thrombocytopenia / Modifyi…

Feat. M. Sekeres
09:05
KU ASH 2019 Review: Current Updates in Hematologic Diseases

ASH 2019 Update on the Higher-Risk MDS: HMA & HCT - Need to Focu…

Feat. M. Sekeres
06:19
KU ASH 2019 Review: Current Updates in Hematologic Diseases

ASH 2019 Update: Adding Targeted Agents to Intensive Therapy in AML …

Feat. H. Male
09:18
KU ASH 2019 Review: Current Updates in Hematologic Diseases

ASH 2019 Update: Understanding the Leukemia Mutational Profile in a …

Feat. H. Male
10:05
KU ASH 2019 Review: Current Updates in Hematologic Diseases

ASH 2019 Update: CC-486 Demonstrated Improvement in OS and RFS in Ma…

Feat. H. Male
36:19
KU ASH 2019 Review: Current Updates in Hematologic Diseases

ASH 2019 Update on Myeloproliferative Neoplasms: CPI-0610 (BET Inhib…

Feat. R. Hoffman
20:32
KU ASH 2019 Review: Current Updates in Hematologic Diseases

ASH 2019 Update on the Bone Marrow Procedures with a Dry Tap: KUH Dr…

Feat. J. Woodroof
30:09
KU ASH 2019 Review: Current Updates in Hematologic Diseases

KU ASH 2019 Review: There Is a Potential Role for Allogeneic HCT Aft…

Feat. H. Abdelhakim
27:18
KU ASH 2019 Review: Current Updates in Hematologic Diseases

KU ASH 2019 Review: Retrospective Analysis of Clinical Outcomes, Tox…

Feat. J. McGuirk
11:50
KU ASH 2019 Review: Current Updates in Hematologic Diseases

KU ASH 2019 Review: CAR T-Cell Therapy is Highly Effective for R/R M…

Feat. J. McGuirk
13:05
KU ASH 2019 Review: Current Updates in Hematologic Diseases

KU ASH 2019 Review on Benign Hematology: Sutimlimab in CAD, Erythrof…

Feat. P. Harris
17:49
KU ASH 2019 Review: Current Updates in Hematologic Diseases

KU ASH 2019 Review on Benign Hematology: New FDA Approvals, 2nd-Line…

Feat. P. Harris